Effect of disease‐modifying agents and their association with mortality in multi‐morbid patients with heart failure with reduced ejection fraction

Abstract Aims An increasing proportion of patients with heart failure with reduced ejection fraction (HFrEF) have co‐morbidities. The effect of these co‐morbidities on modes of death and the effect of disease‐modifying agents in multi‐morbid patients is unknown. Methods and results We performed a pr...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Sam Straw, Melanie McGinlay, Samuel D. Relton, Aaron O. Koshy, John Gierula, Maria F. Paton, Michael Drozd, Judith E Lowry, Charlotte Cole, Richard M Cubbon, Klaus K. Witte, Mark T. Kearney
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Oxford University Press 2020-12-01
Cyfres:	ESC Heart Failure
Pynciau:	Heart failure Sudden cardiac death Co‐morbidities
Mynediad Ar-lein:	https://doi.org/10.1002/ehf2.12978
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!